Max Klement

Max Klement is a Life Science Venture Capital professional based in Greater London, England, with a background in Venture Investments at Novo Holdings and BioGeneration Ventures. He holds an MBA from INSEAD and a Ph.D. from the National University of Singapore, and has invested in companies like Complement Therapeutics at various stages, including Series A and Seed funding. Highlights of Max Klement's career include his roles as Principal at Novo Holdings and BGV, where he focused on investments in sectors such as Pharmaceuticals, BioTech, and Digital Health, and his educational background with a Ph.D. in Life Sciences and an MBA from a prestigious institution like INSEAD.